
A U.S. District Court judge in Massachusetts has found that AstraZeneca, among other companies, violated the Massachusetts consumer protection act by reporting false average wholesale prices for a number of prescription drugs, including goserelin acetate (Zoladex), used in the treatment of prostate cancer.
